|
1 - 10 van 10 voor pharmaceutical companies
N:\...\EINDVERSIE_deel1.w [PFP#1030632807]
... markets in developed countries. already in doha, developing countries were successful in their fight against pharmaceutical companies that charged high prices for medicines against hiv aids. the countries were allowed to produce ...
cpb.nl
N:\publicaties\...\2001_11.wp [PFP#220991162]
... institutes. pharmaceutical companies and manufacturers of basic metals and computer service offices more frequently turn to universities and other research institutes. since pharmaceutical companies designate the ... and universities. the only but most salient exceptions are pharmaceutical companies and companies in public utility and waste disposal companies. 24 we only had a few statistical problems ...
cpb.nl
Microsoft Word - discussion30.doc
... are the main decision-makers and pharmaceutical promotion directed at consumers is not allowed in the netherlands, most of pharmaceutical companies' promotion activities are directed to general ... describes which promotion activities are used by the pharmaceutical industry and discusses the various welfare aspects of promotion by pharmaceutical companies. section 3 details the dutch health care ...
cpb.nl
globalisation and dutch economy pdf
... of international processing activities, based on inputs imported from asian countries. to be more specific, companies and firms located in the industrialised countries of asia (japan, south korea, taiwan, singapore ... almost all products they have an rca close to 1. only beverages (sitc11), medicinal and pharmaceutical products (sitc54) and coin including gold (sitc95) have a rca of larger than 2. a ...
cpb.nl
Microsoft Word - cpbdoc132.doc
... buyer surplus developing a new drug consider the development of a new drug by a pharmaceutical company. if the company is not capable of discriminating between customers, then the company ... migrate from one region to another (see also pelkmans (2006)). instead of voters, also multinational companies may trigger policy competition. member states with a more effective innovation policy might attract ...
cpb.nl
L:\publicaties\...\cpbdoc14.wp [PFP#1112461107]
... d by the companies originating from these countries. swedish companies show the highest activity, whereas danish companies rank lowest. furthermore, american companies outnumber the other foreign companies, but are ... thomson-csf changes corporate name into thales. acquisition 1991 yamanouchi (jap) 1991 acquires pharmaceutical divisions from gist brocades to get access to european market today parent ...
cpb.nl
L:\...\chemical_focus_2.w [PFP#421244934]
... detergents, paints and plastic products. however, major dutch companies like akzo nobel and dsm try to fortify their competences in medicines, pharmaceutical base materials and nutrients, particularly because ... and services upstream industry an industry that produces semi-manufactured products for other companies in downstream industries, and particularly uses raw materials like oil, naphtha etc. ...
cpb.nl
Microsoft Word - rendement onderzoek_v2.doc
... r.w. eberts en m.s. fogarty (1993), universities and the start-up of new companies can we generalise from route 128 and silicon valley?', review of economics and statistics, ... innovation evidence from the pharmaceutical industry', discussion paper stanford institute for economic policy research. ward en dranove (1995), the vertical chain of r d in the pharmaceutical industry', economic inquiry, ...
cpb.nl
Research Memorandum (set-up) [PFP#500828465]
... on an earlier study on the investment interactions in the electronics-, computer-, chemical and pharmaceutical industry (see minne (1997) and (1998)). first, the theoretical basis is improved. second, more ... fields the research of oil companies is only unique in oil refining. in fact, other companies conduct similar research on the research fields of oil companies chemical enterprises carry out the ...
cpb.nl
How Large was the Credit Crunch in the OECD?
... on external finance. ra- jan and zingales use data on publicly traded u.s. manufacturing companies 2 figure 2 banks' loans to non-financial corporations (oecd) trillioneuros outstanding loans (left axis ... countries and industries, in particular they are not driven by any special industry like a pharmaceutical industry. lastly, the interaction of liquidity needs with private credit is not robust. 6.2 ...
cpb.nl
| 